BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2269408)

  • 1. Use of benzhexol hydrochloride to control drooling of children with cerebral palsy.
    Reddihough D; Johnson H; Staples M; Hudson I; Exarchos H
    Dev Med Child Neurol; 1990 Nov; 32(11):985-9. PubMed ID: 2269408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticholinergic medications for reducing drooling in children with developmental disability.
    Reid SM; Westbury C; Guzys AT; Reddihough DS
    Dev Med Child Neurol; 2020 Mar; 62(3):346-353. PubMed ID: 31495925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of drooling with transdermal scopolamine in a child with cerebral palsy.
    Siegel LK; Klingbeil MA
    Dev Med Child Neurol; 1991 Nov; 33(11):1013-4. PubMed ID: 1743423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of trihexyphenidyl in children with cerebral palsy.
    Carranza-del Rio J; Clegg NJ; Moore A; Delgado MR
    Pediatr Neurol; 2011 Mar; 44(3):202-6. PubMed ID: 21310336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of drooling in cerebral palsy: three single case studies.
    Owen SE; Stern ML
    Int J Rehabil Res; 1992; 15(2):166-9. PubMed ID: 1526706
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy.
    Bachrach SJ; Walter RS; Trzcinski K
    Clin Pediatr (Phila); 1998 Aug; 37(8):485-90. PubMed ID: 9729704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modafinil for drooling in cerebral palsy.
    Hurst D; Cedrone N
    J Child Neurol; 2006 Feb; 21(2):112-4. PubMed ID: 16566873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of botulinum neurotoxin A in uncontrolled salivation in children with cerebral palsy: a pilot study.
    Tiigimäe-Saar J; Leibur E; Kolk A; Talvik I; Tamme T
    Int J Oral Maxillofac Surg; 2012 Dec; 41(12):1540-5. PubMed ID: 23068112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care.
    Van der Burg JJ; Jongerius PH; Van Hulst K; Van Limbeek J; Rotteveel JJ
    Dev Med Child Neurol; 2006 Feb; 48(2):103-7. PubMed ID: 16417664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series.
    Jongerius PH; Rotteveel JJ; van den Hoogen F; Joosten F; van Hulst K; Gabreëls FJ
    Eur J Pediatr; 2001 Aug; 160(8):509-12. PubMed ID: 11548191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antireflux medication on salivary drooling in children with cerebral palsy.
    Heine RG; Catto-Smith AG; Reddihough DS
    Dev Med Child Neurol; 1996 Nov; 38(11):1030-6. PubMed ID: 8913184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycopyrrolate treatment of chronic drooling.
    Blasco PA; Stansbury JC
    Arch Pediatr Adolesc Med; 1996 Sep; 150(9):932-5. PubMed ID: 8790123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of drooling with sublingual atropine sulfate in children and adolescents with cerebral palsy.
    Dias BLS; Fernandes AR; Maia HS
    Arq Neuropsiquiatr; 2017 May; 75(5):282-287. PubMed ID: 28591387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute colonic pseudo-obstruction in a child taking trihexyphenidyl for drooling: Prescribers beware.
    Begbie F; Walker G; Kubba H; Sabharwal A
    Int J Pediatr Otorhinolaryngol; 2015 Jun; 79(6):932-934. PubMed ID: 25912627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy.
    Suskind DL; Tilton A
    Laryngoscope; 2002 Jan; 112(1):73-81. PubMed ID: 11802042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drooling therapy in children with neurological disorders].
    Táboas-Pereira MA; Paredes-Mercado C; Alonso-Curcó X; Badosa-Pagès J; Muchart J; Póo P
    Rev Neurol; 2015 Jul; 61(2):66-70. PubMed ID: 26156441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-dependent effects of trihexyphenidyl in extrapyramidal cerebral palsy.
    Hoon AH; Freese PO; Reinhardt EM; Wilson MA; Lawrie WT; Harryman SE; Pidcock FS; Johnston MV
    Pediatr Neurol; 2001 Jul; 25(1):55-8. PubMed ID: 11483397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses.
    Basciani M; Di Rienzo F; Fontana A; Copetti M; Pellegrini F; Intiso D
    Dev Med Child Neurol; 2011 Jun; 53(6):559-64. PubMed ID: 21413974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of drooling in children with cerebral palsy: A French survey.
    Chaléat-Valayer E; Porte M; Buchet-Poyau K; Roumenoff-Turcant F; D'Anjou MC; Boulay C; Bernard JC; Touzet S
    Eur J Paediatr Neurol; 2016 Jul; 20(4):524-31. PubMed ID: 27155820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial.
    Alrefai AH; Aburahma SK; Khader YS
    Clin Neurol Neurosurg; 2009 Jan; 111(1):79-82. PubMed ID: 18977585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.